ID

38009

Descripción

Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01446185

Link

https://clinicaltrials.gov/show/NCT01446185

Palabras clave

Versiones (1)
  1. 8/9/19 8/9/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

8 de septiembre de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT01446185

Inglés

Eligibility Breast Cancer NCT01446185

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients > 18 years old.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
2. pre- or post- menopausal women with breast adenocarcinoma, confirmed by a pathologist and who underwent surgery, with a maximum of 4 weeks between surgery and the 2nd therapeutic decision with oncotype dx.
Descripción

Premenopausal state | Postmenopausal state | Breast adenocarcinoma | Operative Surgical Procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232969
UMLS CUI [2]
C0232970
UMLS CUI [3]
C0858252
UMLS CUI [4]
C0543467
3. hr positive (at least er+) breast cancer patients (defined by a threshold of 10% of the cells ihc + without n- or pn1(mi), her2 - (ihc0, 1, 2+ or fish -)
Descripción

Breast Carcinoma Hormone Receptor Positive | Oestrogen receptor positive breast cancer | Cells Positive Percentage Immunohistochemistry | TNM Breast tumor staging | Breast Carcinoma HER2 Negative | Immunohistochemistry | Fluorescent in Situ Hybridization Negative

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0019929
UMLS CUI [1,3]
C1514241
UMLS CUI [2]
C2938924
UMLS CUI [3,1]
C0007634
UMLS CUI [3,2]
C1514241
UMLS CUI [3,3]
C0439165
UMLS CUI [3,4]
C0021044
UMLS CUI [4]
C0474926
UMLS CUI [5,1]
C0678222
UMLS CUI [5,2]
C2348908
UMLS CUI [6]
C0021044
UMLS CUI [7,1]
C0162789
UMLS CUI [7,2]
C1513916
4. patients must be eligible to receive adjuvant chemotherapy as defined by a good karnofsky index, no hematological, cardiological or hepatic contraindications nor any impeding comorbidity.
Descripción

Patients Eligible Adjuvant Chemotherapy | Karnofsky Performance Status Good | Medical contraindication Hematologic Absent | Medical contraindication cardiac Absent | Medical contraindication Hepatic Absent | Comorbidity Limiting Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1548635
UMLS CUI [1,3]
C0085533
UMLS CUI [2,1]
C0206065
UMLS CUI [2,2]
C0205170
UMLS CUI [3,1]
C1301624
UMLS CUI [3,2]
C0205488
UMLS CUI [3,3]
C0332197
UMLS CUI [4,1]
C1301624
UMLS CUI [4,2]
C0018787
UMLS CUI [4,3]
C0332197
UMLS CUI [5,1]
C1301624
UMLS CUI [5,2]
C0205054
UMLS CUI [5,3]
C0332197
UMLS CUI [6,1]
C0009488
UMLS CUI [6,2]
C0439801
UMLS CUI [6,3]
C0332197
5. patients must have given a written informed consent.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. t3 or t4, hr-, n+ (except pn1 (mi) (sn), her2+ (ihc 3+ or fish+) patients.
Descripción

TNM Breast tumor staging | Breast Carcinoma Hormone Receptor Negative | HER2-positive carcinoma of breast | Immunohistochemistry | FISH Positive

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0474926
UMLS CUI [2,1]
C0678222
UMLS CUI [2,2]
C0019929
UMLS CUI [2,3]
C1513916
UMLS CUI [3]
C1960398
UMLS CUI [4]
C0021044
UMLS CUI [5,1]
C0162789
UMLS CUI [5,2]
C1514241
2. metastatic patients.
Descripción

Patients metastatic

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1522484
3. patients who cannot give an informed consent.
Descripción

Informed Consent Unable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
4. patients who cannot receive chemotherapy.
Descripción

Chemotherapy Receive Unable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1514756
UMLS CUI [1,3]
C1299582
5. patient who participated in another clinical trial and is still in the exclusion period of any other trial.
Descripción

Study Subject Participation Status | Exclusion Period Clinical Trial

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C2828389
UMLS CUI [2,2]
C1948053
UMLS CUI [2,3]
C0008976
6. mentally disabled patient who has no legal responsibility for herself.
Descripción

Mental handicap | Legal responsibility Self Lacking

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1306341
UMLS CUI [2,1]
C0162399
UMLS CUI [2,2]
C0036588
UMLS CUI [2,3]
C0332268
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT01446185

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
1. patients > 18 years old.
boolean
C0001779 (UMLS CUI [1])
Premenopausal state | Postmenopausal state | Breast adenocarcinoma | Operative Surgical Procedure
Item
2. pre- or post- menopausal women with breast adenocarcinoma, confirmed by a pathologist and who underwent surgery, with a maximum of 4 weeks between surgery and the 2nd therapeutic decision with oncotype dx.
boolean
C0232969 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
C0858252 (UMLS CUI [3])
C0543467 (UMLS CUI [4])
Breast Carcinoma Hormone Receptor Positive | Oestrogen receptor positive breast cancer | Cells Positive Percentage Immunohistochemistry | TNM Breast tumor staging | Breast Carcinoma HER2 Negative | Immunohistochemistry | Fluorescent in Situ Hybridization Negative
Item
3. hr positive (at least er+) breast cancer patients (defined by a threshold of 10% of the cells ihc + without n- or pn1(mi), her2 - (ihc0, 1, 2+ or fish -)
boolean
C0678222 (UMLS CUI [1,1])
C0019929 (UMLS CUI [1,2])
C1514241 (UMLS CUI [1,3])
C2938924 (UMLS CUI [2])
C0007634 (UMLS CUI [3,1])
C1514241 (UMLS CUI [3,2])
C0439165 (UMLS CUI [3,3])
C0021044 (UMLS CUI [3,4])
C0474926 (UMLS CUI [4])
C0678222 (UMLS CUI [5,1])
C2348908 (UMLS CUI [5,2])
C0021044 (UMLS CUI [6])
C0162789 (UMLS CUI [7,1])
C1513916 (UMLS CUI [7,2])
Patients Eligible Adjuvant Chemotherapy | Karnofsky Performance Status Good | Medical contraindication Hematologic Absent | Medical contraindication cardiac Absent | Medical contraindication Hepatic Absent | Comorbidity Limiting Absent
Item
4. patients must be eligible to receive adjuvant chemotherapy as defined by a good karnofsky index, no hematological, cardiological or hepatic contraindications nor any impeding comorbidity.
boolean
C0030705 (UMLS CUI [1,1])
C1548635 (UMLS CUI [1,2])
C0085533 (UMLS CUI [1,3])
C0206065 (UMLS CUI [2,1])
C0205170 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0205488 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
C1301624 (UMLS CUI [4,1])
C0018787 (UMLS CUI [4,2])
C0332197 (UMLS CUI [4,3])
C1301624 (UMLS CUI [5,1])
C0205054 (UMLS CUI [5,2])
C0332197 (UMLS CUI [5,3])
C0009488 (UMLS CUI [6,1])
C0439801 (UMLS CUI [6,2])
C0332197 (UMLS CUI [6,3])
Informed Consent
Item
5. patients must have given a written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
TNM Breast tumor staging | Breast Carcinoma Hormone Receptor Negative | HER2-positive carcinoma of breast | Immunohistochemistry | FISH Positive
Item
1. t3 or t4, hr-, n+ (except pn1 (mi) (sn), her2+ (ihc 3+ or fish+) patients.
boolean
C0474926 (UMLS CUI [1])
C0678222 (UMLS CUI [2,1])
C0019929 (UMLS CUI [2,2])
C1513916 (UMLS CUI [2,3])
C1960398 (UMLS CUI [3])
C0021044 (UMLS CUI [4])
C0162789 (UMLS CUI [5,1])
C1514241 (UMLS CUI [5,2])
Patients metastatic
Item
2. metastatic patients.
boolean
C0030705 (UMLS CUI [1,1])
C1522484 (UMLS CUI [1,2])
Informed Consent Unable
Item
3. patients who cannot give an informed consent.
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Chemotherapy Receive Unable
Item
4. patients who cannot receive chemotherapy.
boolean
C0392920 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
Study Subject Participation Status | Exclusion Period Clinical Trial
Item
5. patient who participated in another clinical trial and is still in the exclusion period of any other trial.
boolean
C2348568 (UMLS CUI [1])
C2828389 (UMLS CUI [2,1])
C1948053 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
Mental handicap | Legal responsibility Self Lacking
Item
6. mentally disabled patient who has no legal responsibility for herself.
boolean
C1306341 (UMLS CUI [1])
C0162399 (UMLS CUI [2,1])
C0036588 (UMLS CUI [2,2])
C0332268 (UMLS CUI [2,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial